Concepedia

Erika M. Gaglione

EM

Statistics

Publications

11

Citations

558

H-Index

10

Active since

2020

Affiliations

National Heart Lung and Blood Institute(Current)

National Institutes of Health

University of America

AbbVie (United States)

Scripps Research Institute

Erika M. Gaglione is an author at National Heart Lung and Blood Institute specializing in cell biology, medicine, and immune regulation.

ORCID

Top concepts

Publications per year

2020–2023

11

Publications

11

Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines

Christopher Pleyer, Mir A. Ali, Jeffrey I. Cohen et al. · Blood · 2020 · 134 citations · Full text

Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib: Development and Validation of a Four-Factor Prognostic Model

Inhye E. Ahn, Xin Tian, David Ipe et al. · Journal of Clinical Oncology · 2020 · 102 citations · Full text

Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib

Clare Sun, Pia Nierman, Ellen K. Kendall et al. · Blood · 2020 · 101 citations · Full text

Overcoming Acquired Epigenetic Resistance to BTK Inhibitors

Arthur L. Shaffer, James D. Phelan, James Q. Wang et al. · Blood Cancer Discovery · 2021 · 56 citations · Full text

Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting

Maissa Mhibik, Erika M. Gaglione, David Eik et al. · Blood Advances · 2023 · 35 citations · Full text

, , +15

1–5 of 11